Study phase | Systolic pressure (mm Hg) | Diastolic pressure (mm Hg) | Heart rate (beats/min) | End diastolic LV pressure (mm Hg) | LV dP/dt max (mm Hg/s) | Segment shortening (%) | Mean coronary blood flow (mL/min) |
---|---|---|---|---|---|---|---|
Baseline | 113 ± 16 | 76 ± 14 | 95 ± 21 | 8 ± 3 | 1,631 ± 361 | 17.1 ± 3.8 | 31 ± 13 |
Ischemia | 110 ± 14 | 77 ± 13 | 110 ± 23 | 10 ± 5 | 1,384 ± 388 | 8.5 ± 4.1* | 18 ± 9* |
Ischemia + dipyridamole | 81 ± 11*† | 45 ± 8*† | 114 ± 21 | 8 ± 3 | 1,361 ± 239 | 11.2 ± 5.2* | 30 ± 7† |